Pesquisas alternativas:
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
doses novel » dose novel (Expandir a Pesquisa), does novel (Expandir a Pesquisa), uses novel (Expandir a Pesquisa)
novel ether » novel tethered (Expandir a Pesquisa), novelli ethel (Expandir a Pesquisa), novel fathers (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
doses novel » dose novel (Expandir a Pesquisa), does novel (Expandir a Pesquisa), uses novel (Expandir a Pesquisa)
novel ether » novel tethered (Expandir a Pesquisa), novelli ethel (Expandir a Pesquisa), novel fathers (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
1
Por Wang, Zhonglei, Yang, Liyan, Cui, Shuai, Liang, Yingxi, Zhang, Xiaohua
Publicado no Molecules (2014)
“...A novel twin drug consisting of nicotinic acid (VB3) and quercetin tetramethyl ether (QTME) has...”Publicado no Molecules (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado no Oncologist (2017)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... could be based on an "all or none" detection of the marker rather than on drug levels....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
5
Por Yadav, Bhagwan, Wennerberg, Krister, Aittokallio, Tero, Tang, Jing
Publicado no Comput Struct Biotechnol J (2015)
“... positive rate at a low level. Further, rather than relying on a single parameter to assess drug interaction...”Publicado no Comput Struct Biotechnol J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
7
Por Supp, Gernot G., Higgen, Focko L., Hipp, Joerg F., Engel, Andreas K., Siegel, Markus
Publicado no Front Pharmacol (2018)
“... AEPs during remifentanil medication. This decrease was predicted by drug dose, rather than sedation...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Everson, Frans, Genis, Amanda, Ogundipe, Temitope, De Boever, Patrick, Goswami, Nandu, Lochner, Amanda, Blackhurst, Dee, Strijdom, Hans
Publicado no PLoS One (2018)
“...HIV-infection, certain antiretroviral drug classes, especially protease inhibitors (PI...”Publicado no PLoS One (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“...The drug edelfosine is a synthetic analog of 2-lysophosphatidylcholine. Edelfosine is incorporated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Publicado no Lancet
(2019)
“... cycles, or by giving individual drugs sequentially at full dose rather than in lower-dose concurrent...”Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Xu, Guoyan G., Pagare, Piyusha P., Ghatge, Mohini S., Safo, Ronni P., Gazi, Aheema, Chen, Qiukan, David, Tanya, Alabbas, Alhumaidi B., Musayev, Faik N., Venitz, Jürgen, Zhang, Yan, Safo, Martin K., Abdulmalik, Osheiza
Publicado no Mol Pharm (2017)
“... efforts to develop novel efficacious drugs with improved pharmacologic properties, we structurally...”Publicado no Mol Pharm (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Rosenheck, Robert A, Davis, Vicki G., Davis, Sonia M, Stroup, Scott, McEvoy, Joseph, Swartz, Marvin, Lieberman, Jeffrey
Publicado no Schizophr Res (2009)
“..., especially at high capsule levels, than drugs that were dosed at lower relative strengths. METHODS: CATIE...”Publicado no Schizophr Res (2009)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... ALT levels were increased at 6 hours after dosing in hUGT1 mice and at 24 hours after dosing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Cheruiyot, Agnes C., Auschwitz, Jennifer M., Lee, Patricia J., Yeda, Redemptah A., Okello, Charles O., Leed, Susan E., Talwar, Mayank, Murthy, Tushar, Gaona, Heather W., Hickman, Mark R., Akala, Hoseah M., Kamau, Edwin, Johnson, Jacob D.
Publicado no Antimicrob Agents Chemother (2016)
“... isolates with various low levels of parasitemia. To be advantageous, malaria drug sensitivity assays should...”Publicado no Antimicrob Agents Chemother (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Rahman, Raziur, Dhruba, Saugato Rahman, Ghosh, Souparno, Pal, Ranadip
Publicado no Sci Rep (2019)
“... drug sensitivity profile which can be used to design the optimal dose for a patient. In this article...”Publicado no Sci Rep (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por de Cates, Angharad N, Farr, Matthew RB, Wright, Nicola, Jarvis, Morag C, Rees, Karen, Ebrahim, Shah, Huffman, Mark D
Publicado em 2014
“.... Fixed-dose combination therapy improved adherence to a multi-drug strategy by 33% (26% to 41%) compared...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... years and 65 years and older, and between those treated with a low and a high dose of each drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... antiproliferative pro-drugs. RESULTS: A series of novel CA-4 derivatives, which contained a 3’-O-substituted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... situations, blood levels of the drugs are inadequate because of poor drug quality rather than poor absorption...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo